ResultsMoneycontrol
Tatva Chintan sales up 79% to Rs 207.48 crore
Positive+202 sources
GreyOak summary
Tatva Chintan Pharma Chem reported standalone net sales of Rs 207.48 crore in September 2026, a 79.08% increase from the previous year. Quarterly net profit rose to Rs 15.39 crore, while EPS reached Rs 6.57. The company's shares closed at Rs 1,665.60 on November 4, 2026.
What it affects
- Tatva Chintan Pharma ChemTATVAPositive +20
Sales and profit surged significantly year-on-year.Rolling sentiment Positive +39
Source
Read the original at MoneycontrolMore Tatva Chintan Pharma Chem news
No other recent stories about Tatva Chintan Pharma Chem.
All Tatva Chintan Pharma Chem news →